Microchip Versus Piezoelectric Point of Care Ultrasonography for Pulmonary and Vena Cava Evaluation in Patients With Acute Kidney Injury

微芯片与压电式床旁超声在急性肾损伤患者肺部和下腔静脉评估中的比较

阅读:1

Abstract

INTRODUCTION: Point-of-care ultrasonography (POCUS) has emerged as an important tool for examining critically ill patients. POCUS devices have become progressively smaller and more accessible, transforming medical practice, and reducing costs. One technological breakthrough was the development of ultraportable scanners with microchip technology, which utilize a probe connected to a smartphone or tablet and incorporate a mobile application that employs artificial intelligence to assist in the interpretation of acquired images. The aim of this study was to compare the accuracy of ultrasound microchip technology with traditional piezoelectric crystal ultrasonography. We analyzed 2 volume status parameters in intensive care unit (ICU) patients with acute kidney injury (AKI) who were receiving kidney replacement therapy (KRT). These parameters were the extravascular pulmonary water, using the lung B-lines; and the inferior vena cava collapsibility index (IVCi). METHODS: Fifty critically ill patients met the study criteria. Lung POCUS quantified B-lines in 8 quadrants. The IVCi was measured using the maximum and minimum diameters during a respiratory cycle. Both technologies were sequentially employed in a randomized fashion to acquire the parameters at 2 different time points: before the initiation of KRT (T0) and 60 minutes after the procedure had commenced (T60). We calculated the correlation and agreement between the 2 ultrasound scanner modalities. RESULTS: The correlation between the 2 technologies for evaluating lung B-lines showed strong positive coefficients, ⍴ = 0.96 and ⍴ = 0.93 at T0 and T60, respectively (P < 0.001 for both). The correlation for IVCi was ρ = 0.70 and ρ = 0.87 at T0 and T60, respectively (P < 0.001 for both). The Bland-Altman plots showed agreement between ultrasound methods for IVCi calculation and B-line quantification. For IVCi calculation at T0, bias was +2.69 (SD: 10.6) (95% confidence interval [CI]: -18.13 to +23.52); at T60, bias was 3.28 (SD: 10.23) (95% CI: -16.77 to +23.34). For B-line quantification, the analysis yielded a bias of -0.3 (SD: 2.73), with a 95% CI of -5.66 to +5.06 at T0; and a bias of 0.2 (SD: 3.23), with a 95% CI of -6.14 to +6.54 at T60. CONCLUSION: Our study observed a good correlation and agreement between microchip and piezoelectric-based ultrasound modalities in evaluating the presence of pulmonary B-lines and inferior vena cava (IVC) dynamics in patients with AKI. Microchip ultrasound, in addition to being portable, user-friendly, and cost-effective, consistently delivers bedside parameters for volume assessment that are comparable to those obtained through POCUS using piezoelectric transducer-based ultrasonography.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。